Stay updated on T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA new version entry, Revision: v3.5.4, was added to the Record History, replacing the previous Revision: v3.5.3 and signaling an update to the study record.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now displays an updated UI/release revision label (Revision: v3.5.3 instead of v3.5.2), reflecting a site/version update rather than a change to the underlying study record.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded Revision: v3.5.2 and Deleted Revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3 from the record history.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check101 days agoChange DetectedA new revision entry v3.4.2 was added to the study record history, and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.